Targeting Applications of Biotinylated Liposomes

References

• Cavallaro U., del Vecchio A., Lappi D. A., Soria M. R. A conjugate between human urokinase and saporin, a type 1 ribosome-inactivating protein, is selectively cytotoxic in urokinase receptor-expressing cells. J. Biol. Chem. 1993, in press
   Web of Science ®Google Scholar
• Soria M. R., Benatti L., Ceriotti A., Vitale A., Lappi D. A. Ribosome-inactivating proteins from Saponaria officinalis: tools in the design of immunotoxins and ligand toxins. “Targeting of drugs 3: the challenge of peptides and proteins”, G. Gregoriadis, A. C. Allison, G. Poste. Plenum Press, New York 1992; 19–29
   Google Scholar
• Cobb L. Intratumor factors influencing the access of antibody to tumor cells. Cancer Immunology and Immunotherapy 1989; 28: 235
   PubMed Web of Science ®Google Scholar
• Ito T., Griffin T. W., Collins J. A., Brill A. B. Intratumoral and whole-body distributions of C110 anti-carcino embryonic antigen radioimmunotoxin after intraperitoneal and intravenous injection: a quantitative autoradiographic study. Cancer Res. 1992; 52: 1961–1967
   PubMed Web of Science ®Google Scholar
• Baxter L. T., Jain R. K. Transport of fluid and macromolecules in tumors. IV. A microscopic model of the perivascular distribution. Microvasc. Res. 1991; 41: 252–272
   PubMed Web of Science ®Google Scholar
• van Osdol W., Fujimori K., Weinstein J. N. An analysis of monoclonal antibody distribution in microscopic tumor nodules: consequences of a “binding site barrier”. Cancer Res. 1991; 51: 4776–4784
   PubMed Web of Science ®Google Scholar
• Ostro M. J. Liposomes from biophysics to therapeutics. Marcel Dekker, New York 1987
   Google Scholar
• Presant C. A., Proffitt R. T., Turner A. F., Williams L. E., Winsor D., Werner J. L., Kennedy P., Wiseman C., Gala K., McKenna R. J., et al. Successful imaging of human cancer with indium-111-labeled phospholipid vesicles. Cancer 1988; 62: 905–911
   PubMed Web of Science ®Google Scholar
• Gabizon A., Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA 1988; 85: 6949–6953
   PubMed Web of Science ®Google Scholar
• Papahadjopoulos D., Allen T. M., Gabizon A., Mayhew E., Matthay K., Huang S. K., Lee K.-D., Woodle M. C., Lasic D. D., Redemann C., Martin F. J. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA 1991; 88: 11460–11464
   PubMed Web of Science ®Google Scholar
• Loughrey H. C., Bally M. B., Cullis P. R. A non-covalent method of attaching antibodies to liposomes. Biochim. Biophys. Acta 1987; 901: 157–160
   PubMed Web of Science ®Google Scholar
• Loughrey H. C., Choi L. S., Cullis P. R., Bally M. B. Optimized procedures for the coupling of proteins to liposomes. Immunol J. Meth. 1990; 132: 25–35
   PubMed Web of Science ®Google Scholar
• Leserman L. D., Barbet J., Kourilsky F., Weinstein J. N. Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A. Nature 1980; 288: 602–604
   PubMed Web of Science ®Google Scholar
• Martin F. J., Papahadjopoulos D. Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting. J. Biol. Chem. 1982; 257: 286–288
   PubMed Web of Science ®Google Scholar
• Loughrey H. C., Wong K. F., Choi L. S., Cullis P. R., Bally M. B. Protein-liposome conjugates with defined size distributions. Biochim. Biophys. Acta 1990; 1028: 73–81
   PubMed Web of Science ®Google Scholar
• Paganelli G., Pervez S., Siccardi A. G., Rowlinson G., Deleide Chiolerio F., Malcovati M., Sacassellati A., Epenetos A. A. Intraperitoneal radio-localization of tumors pre-targeted by biotinylated monoclonal antibodies. Int. J. Cancer 1990; 45: 1184–1189
   PubMed Web of Science ®Google Scholar
• Paganelli G., Magnani P., Zito F., Villa E., Sudati F., Lopalco L., Rossetti C., Malcovati M., Chiolerio F., Seccamani E., Siccardi A. G., Fazio F. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res. 1991; 51: 5960–5966
   PubMed Web of Science ®Google Scholar
• Mayer L. D., Bally M. B., Hope M. J., Cullis P. R. Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochim. Biophys. Acta 1985; 816: 294–302
   PubMed Web of Science ®Google Scholar
• Mauk M. R., Gamble R. C. Preparation of lipid vesicles containing high levels of entrapped radioactive cations. Anal. Biochem. 1979; 94: 302–307
   PubMed Web of Science ®Google Scholar
• Loughrey H., Ferraretto A., Cannon A. M., Acerbis G., Sudati F., Bottiroli G., Masserini M., Soria M. R. Characterisation of biotinylated liposomes for in vivo targeting applications, Submitted for publication
   Google Scholar
• Mayer L. D., Hope M. J., Cullis P. R. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim. Biophys. Acta 1986; 858: 161–168
   PubMed Web of Science ®Google Scholar
• Corley, Loughrey H. C., manuscript in preparation
   Google Scholar
• Mori A., Klibanov A. L., Torchilin V. P., Huang L. Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett. 1991; 284: 263–266
   PubMed Web of Science ®Google Scholar
• Oghihara-Umeda I., Sasaki T., Nishigori H. Active removal of radioactivity in the blood circulation using biotin-bearing liposomes and avidin for rapid tumor imaging. Eur. J. Nucl. Med. 1993; 20: 170–172
   PubMedGoogle Scholar
• Huang S. K., Lee K. D., Hong K., Friend D. S., Papahadjopoulos D. Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res. 1992; 52: 5135–5143
   PubMed Web of Science ®Google Scholar